RN7SK pseudogene 113 (RN7SKP113)

RN7SK pseudogene 113 (abbreviated RN7SKP113) is classified as a pseudogene of the RNA, 7SK small nuclear (RN7SK) gene[3]. Unlike functional genes, a pseudogene does not produce a functional product and is generally considered non-coding. RN7SK itself is a small nuclear RNA that plays a key role in regulating transcription elongation by sequestering and inhibiting the positive transcription elongation factor P-TEFb[1]. However, RN7SKP113, as a pseudogene, is not known to encode a functional RNA or protein, nor is it recognized as a molecular target in therapeutics, biomarker research, or disease roles[3]. There is no evidence of RN7SKP113 being directly involved in any known biological process, disease, or as a target for drugs and therapeutics. The entry represents either a non-functional, duplicated, or processed version of the original 7SK gene, with no active biological function or pharmacological relevance. Note: - This entry is considered incorrect as a therapeutic target because pseudogenes are not functional gene products, and there is no evidence that RN7SKP113 is used as a receptor, drug target, biomarker, or has any direct biological function in disease[3]. - All disease associations and functional descriptions apply to the functional 7SK RNA, not the pseudogene RN7SKP113[3][5][1].

Other names

RNA, 7SK small nuclear pseudogene 113RN7SKP113